A Penticton woman who refused to take the COVID-19 vaccine and subsequently lost her job, sending her on the \ ...

Furthermore, Indivior’s extended-release buprenorphine, SUBLOCADE, has shown efficacy in reducing opioid use in patients with opioid use disorder, as demonstrated in a recent clinical trial. The trial ...

(RTTNews) - Indivior PLC (INDV) on Thursday has shared its financial outlook for 2026, pointing to anticipated revenue growth and improved profit margins, largely thanks to SUBLOCADE. The company ...

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

Those who are undergoing medication-assisted treatment for opioid addiction can now get access to those treatments through Franklin County Municipal Court. Shots of Sublocade and Vivitrol are ...

Indivior PLC (NASDAQ:INDV) is one of the best performing pharma stocks in 2025. Indivior PLC (NASDAQ:INDV) announced its full-year 2026 financial guidance on January 8, reporting that the total net ...